Vnitr Lek 2013, 59(2):127-131

Ischemic peripheral arterial disease and recurrent iliofemoral venous thrombosis in a 24-year-old man with antiphospholipid syndrome

D. Ručka*, K. Bojanovská, S. Heller, P. Procházka, L. Skalická, P. Vařejka, M. Chochola, A. Linhart, D. Karetová
Second Department of Internal Medicine - Cardiology and Angiology, General University Hospital in Prague, First Faculty of Medicine, Charles University in Prague, head prof. MUDr. Aleš Linhart, DrSc.

The following is a case report of a young man with antiphospholipid syndrome, present with a recurrent iliofemoral venous thrombosis and premature peripheral arterial disease. This case report highlights the high risk of recurrent thrombosis upon discontinuation of anticoagulation therapy, particularly in the presence of persistent spontaneously increased aPTT and a high antiphospholipid antibody titer. The case report also reviews the potential of endovascular treatment of iliac vein thrombosis and points out the good 24-month patency rates of stents implanted into the pelvic vein region.

Keywords: antiphospholipid syndrome; iliofemoral deep vein thrombosis; recurrent thrombosis; accelerated atherosclerosis; peripheral arterial disease

Received: December 3, 2012; Accepted: January 15, 2013; Published: February 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ručka D, Bojanovská K, Heller S, Procházka P, Skalická L, Vařejka P, et al.. Ischemic peripheral arterial disease and recurrent iliofemoral venous thrombosis in a 24-year-old man with antiphospholipid syndrome. Vnitr Lek. 2013;59(2):127-131.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763. Go to original source... Go to PubMed...
    2. Miyakis S et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306. Go to original source... Go to PubMed...
    3. Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford) 2007; 46: 1641-1647. Go to original source... Go to PubMed...
    4. Ames PR et al. Atherosclerosis in thrombotic primary antiphospholipid syndrome. J Thromb Haemost 2009; 7: 537-542. Go to original source... Go to PubMed...
    5. Farmer-Boatwright MK, Roubey RA. Venous thrombosis in the antiphospholipid syndrome. Arterioscler Thromb Vasc Biol 2009; 29: 321-325. Go to original source... Go to PubMed...
    6. Ruiz-Irastorza G, Khamashta MA. Stroke and antiphospholipid syndrome: the treatment debate. Rheumatology (Oxford) 2005; 44: 971-974. Go to original source... Go to PubMed...
    7. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487-494. Go to original source... Go to PubMed...
    8. Varejka P, Chochola M, Jirat S et al. Cathetrization treatment of deep venous thrombosis, early and long-term outcomes. Interní Med 2004; 12: 576-580.
    9. Hirmerová J, Ulcová-Gallová Z, Seidlerová J et al. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism. Clin Appl Thromb Hemost 2010; 16: 318-325. Go to original source... Go to PubMed...
    10. Arnout J. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thromb Haemost 2001; 86: 83-91. Go to original source... Go to PubMed...
    11. Espinosa G, Cervera R. Antiphospholipid syndrome. Arthritis Res Ther 2008; 10: 230. Go to original source... Go to PubMed...
    12. Buliková A, Zavřelová J, Penka M. Antiphospholipid syndrome in the year 2009. Vnitř Lék 2009; 55: 253-262. Go to PubMed...
    13. Weissman A, Coplan NL. Antiphospholipid antibody syndrome and acute stent thrombosis. Rev Cardiovasc Med 2006; 7: 244-246. Go to PubMed...
    14. Middlebrooks EH, Panda M. Multiple recurrent stent thrombosis in a patient with coexisting clopidogrel resistance and increased anticardiolipin antibodies: a case report. Case Report Med 2010: 974149. Go to original source... Go to PubMed...
    15. Kearon C et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: (6 Suppl.): 454S-545S. Go to original source...
    16. Crowther MA et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 1133-1138. Go to original source... Go to PubMed...
    17. Mohr JP et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444-1451. Go to original source... Go to PubMed...
    18. Wajed J et al. Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management. Rheumatology (Oxford) 2004; 43: 7-12. Go to original source... Go to PubMed...
    19. Lim W et al. Phospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program 2009; 233-239. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.